These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1130 related articles for article (PubMed ID: 14559811)

  • 21. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
    Metser U; Even-Sapir E
    Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.
    Bradley J; Thorstad WL; Mutic S; Miller TR; Dehdashti F; Siegel BA; Bosch W; Bertrand RJ
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):78-86. PubMed ID: 15093902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative image fusion of fluoro-2-deoxy-D-glucose-positron emission tomography and computed tomography data sets in oral maxillofacial carcinoma: potential clinical value.
    Wolf G; Nicoletti R; Schultes G; Schwarz T; Schaffler G; Aigner RM
    J Comput Assist Tomogr; 2003; 27(6):889-95. PubMed ID: 14600456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of 11-C-methionine positron emission tomography for the delineation of the tumor volume in pharyngo-laryngeal squamous cell carcinoma: comparison with FDG-PET and CT.
    Geets X; Daisne JF; Gregoire V; Hamoir M; Lonneux M
    Radiother Oncol; 2004 Jun; 71(3):267-73. PubMed ID: 15172141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positron emission tomography/computed tomography.
    Townsend DW
    Semin Nucl Med; 2008 May; 38(3):152-66. PubMed ID: 18396176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FDG imaging of lung nodules: a phantom study comparing SPECT, camera-based PET, and dedicated PET.
    Coleman RE; Laymon CM; Turkington TG
    Radiology; 1999 Mar; 210(3):823-8. PubMed ID: 10207487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 18F-FDG-PET partial volume effect correction using a modified recovery coefficient approach based on functional volume and local contrast: physical validation and clinical feasibility in oncology.
    Anouan KJ; Lelandais B; Edet-Sanson A; Ruan S; Vera P; Gardin I; Hapdey S
    Q J Nucl Med Mol Imaging; 2017 Sep; 61(3):301-313. PubMed ID: 26407135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feasibility of imaging photodynamic injury to tumours by high-resolution positron emission tomography.
    Moore JV; Waller ML; Zhao S; Dodd NJ; Acton PD; Jeavons AP; Hastings DL
    Eur J Nucl Med; 1998 Sep; 25(9):1248-54. PubMed ID: 9724373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiopharmacological evaluation of 6-deoxy-6-[18F]fluoro-D-fructose as a radiotracer for PET imaging of GLUT5 in breast cancer.
    Wuest M; Trayner BJ; Grant TN; Jans HS; Mercer JR; Murray D; West FG; McEwan AJ; Wuest F; Cheeseman CI
    Nucl Med Biol; 2011 May; 38(4):461-75. PubMed ID: 21531283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Small animal tumour imaging with MRI and the ECAT EXACT scanner: application of partial volume correction and comparison with microPET data.
    Helisch A; Thews O; Buchholz HG; Tillmanns J; Kronfeld A; Schreiber LM; Schreckenberger M; Bartenstein P
    Nucl Med Commun; 2010 Apr; 31(4):294-300. PubMed ID: 20023592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radioiodinated phenylalanine derivatives to image pancreatic cancer: a comparative study with [18F]fluoro-2-deoxy-D-glucose in human pancreatic carcinoma xenografts and in inflammation models.
    Hellwig D; Menges M; Schneider G; Moellers MO; Romeike BF; Menger MD; Kirsch CM; Samnick S
    Nucl Med Biol; 2005 Feb; 32(2):137-45. PubMed ID: 15721759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Artifactual 2-deoxy-2-[(18)F]fluoro-D-glucose localization surrounding metallic objects in a PET/CT scanner using CT-based attenuation correction.
    Bujenovic S; Mannting F; Chakrabarti R; Ladnier D
    Mol Imaging Biol; 2003; 5(1):20-2. PubMed ID: 14499157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograft-bearing nude mice.
    Verel I; Visser GW; Boellaard R; Boerman OC; van Eerd J; Snow GB; Lammertsma AA; van Dongen GA
    J Nucl Med; 2003 Oct; 44(10):1663-70. PubMed ID: 14530484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo tumor imaging in mice using a state-of-the-art clinical PET/CT in comparison with a small animal PET and a small animal CT.
    Seemann MD; Beck R; Ziegler S
    Technol Cancer Res Treat; 2006 Oct; 5(5):537-42. PubMed ID: 16981797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical usefulness of FDG-PET in oncology].
    Sasaki M
    Nihon Igaku Hoshasen Gakkai Zasshi; 2001 Jul; 61(8):414-20. PubMed ID: 11524817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation.
    Anderson GS; Brinkmann F; Soulen MC; Alavi A; Zhuang H
    Clin Nucl Med; 2003 Mar; 28(3):192-7. PubMed ID: 12592125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of tumoricidal efficacy and response to treatment with 18F-FDG PET/CT after intraarterial infusion with the antiglycolytic agent 3-bromopyruvate in the VX2 model of liver tumor.
    Liapi E; Geschwind JF; Vali M; Khwaja AA; Prieto-Ventura V; Buijs M; Vossen JA; Ganapathy-Kanniappan S; Wahl RL
    J Nucl Med; 2011 Feb; 52(2):225-30. PubMed ID: 21233194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An introduction to PET-CT imaging.
    Kapoor V; McCook BM; Torok FS
    Radiographics; 2004; 24(2):523-43. PubMed ID: 15026598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical relevance of fusion images using (18)F-2-fluoro-2-deoxy-D-glucose positron emission tomography in local recurrence of rectal cancer.
    Fukunaga H; Sekimoto M; Tatsumi M; Ikenaga M; Ohue M; Seshimo I; Higuchi I; Takayama O; Yasui M; Ikeda M; Yamamoto H; Monden M
    Int J Oncol; 2002 Apr; 20(4):691-5. PubMed ID: 11894111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncologic diagnosis with 2-[fluorine-18]fluoro-2-deoxy-D-glucose imaging: dual-head coincidence gamma camera versus positron emission tomographic scanner.
    Shreve PD; Steventon RS; Deters EC; Kison PV; Gross MD; Wahl RL
    Radiology; 1998 May; 207(2):431-7. PubMed ID: 9577492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.